24654-55-5

Basic information

• Product Name: 4-Fluorocinnamaldehyde
• Synonyms: CHEMBRDG-BB 4004292;4-FLUOROCINNAMALDEHYDE;2-PROPENAL, 3-(4-FLUOROPHENYL)-,(2E);4-FLUOROCINNAMALDEHYDE 98+%;p-Fluorocinnamaldehyde;(E)-3-(4-fluorophenyl)acrylaldehyde;4-Fluorociamaldehyde;3-(4-Fluorophenyl)acrylaldehyde 3-(4-Fluorophenyl)-2-propenal
• CAS NO: 24654-55-5
• Molecular Formula: C₉H₇FO
• Molecular Weight: 150.15
• Product Categories: Aromatic Aldehydes & Derivatives (substituted)
• Mol File: 24654-55-5.mol

Chemical Properties

• Melting Point: 24°C
• Boiling Point: 102-104°C
• Flash Point: 91.3 °C
• Appearance: Light yellow crystalline
• Density: 1.18
• Vapor Pressure: 0.0284mmHg at 25°C
• Refractive Index: 1.5960-1.6010
• Storage Temp.: 0-10°C
• CAS DataBase Reference: 4-Fluorocinnamaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Fluorocinnamaldehyde(24654-55-5)
• EPA Substance Registry System: 4-Fluorocinnamaldehyde(24654-55-5)

Safety Data

• Hazardous Substances Data: 24654-55-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
4-Fluorocinnamaldehyde is utilized as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique chemical structure allows for the creation of a wide array of medicinal agents, contributing to the development of new treatments and therapies.
Used in Fragrance and Flavor Industry:
Leveraging its pleasant aromatic properties, 4-Fluorocinnamaldehyde is employed as a component in the manufacture of fragrances and flavors. Its strong odor makes it a valuable addition to the creation of scents and taste profiles in consumer products, enhancing the sensory experience.
Used in Antimicrobial Applications:
4-Fluorocinnamaldehyde has been studied for its potential antimicrobial properties, making it a candidate for use in applications where the inhibition of microbial growth is necessary, such as in preservatives for food and cosmetics, or in the development of new antimicrobial agents.
Used in Antioxidant Applications:
4-Fluorocinnamaldehyde's antioxidant potential has also been recognized, suggesting its use in applications requiring protection against oxidative stress. This could include roles in the food industry to prevent spoilage, in cosmetic formulations to protect against environmental damage, or in pharmaceuticals to combat oxidative stress-related diseases.

InChI:InChI=1/C9H7FO/c10-9-5-3-8(4-6-9)2-1-7-11/h1-7H/b2-1-

Upstream product

• 819066-29-0 1-((E)-3,3-Diethoxy-propenyl)-4-fluoro-benzene 
• 459-57-4 4-fluorobenzaldehyde 
• 75-07-0 acetaldehyde 
• 124980-95-6 (E)-3-(4-fluorophenyl)-2-propen-1-ol 
• 405-99-2 para-fluorostyrene 
• 123-73-9 crotonaldehyde 
• 107-02-8 acrolein 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 3054-95-3 acrylaldehyde diethyl acetal 
• 352-34-1 4-fluoro-1-iodobenzene 
• 2136-75-6 (triphenylphosphoranylidene)acetaldehyde 
• 106485-14-7 1-((E)-3,3-Diethoxy-propenyl)-4-fluoro-benzene 
• 136265-10-6 ethyl 4-fluorocinnamate 
• 121-44-8 triethylamine 

Downstream Products

• 106485-06-7 (Z)-4-Fluorzimtaldoxim 
• 863970-22-3 (S)-3-(4-fluorophenyl)-3-phenylpropanal 
• 873316-17-7 (1E,3S)-(-)-1-(4-Fluorophenyl)hexa-1,5-dien-3-ol 
• 188869-25-2 (-)-trans-1-benzyl-3-hydroxymethyl-4-(4-fluorophenyl)piperidine 

Relevant articles and documents

An efficient Pd@Pro-GO heterogeneous catalyst for the α, β-dehydrogenation of saturated aldehyde and ketones

An Efficient Pd@Pro-GO heterogeneous catalyst was developed that can promote the α, β-dehydrogenation of saturated aldehyde and ketones in the yield of 73% ? 92% at mild conditions without extra oxidants and additives. Pd@Pro-GO heterogeneous catalyst was synthesized via two steps: firstly, the Pro-GO was obtained by the esterification reaction between graphene oxide (GO) and N-(tert-Butoxycarbonyl)-L-proline (Boc-Pro-OH), followed by removing the protection group tert-Butoxycarbonyl (Boc), which endowed the proline-functionalized GO with both the lewis acid site (COOH) and the bronsted base site (NH), besides, the pyrrolidine of proline also can form imine with aldehydes to activate these substrates; Second, palladium was dispersed on the proline-functionalized GO (Pro-GO) to obtained heterogeneous catalyst Pd@Pro-GO. Mechanistic studies have shown that the Pd@Pro-GO-catalyzed α,β-dehydrogenation of saturated aldehyde and ketones was realized by an improved heterogeneously catalyzed Saegusa oxidation reaction. Based on the obove characteristics, the Pd@Pro-GO will be widely used in the transition metal catalytic field.

TREATMENT OF DISORDERS ASSOCIATED WITH OXIDATIVE STRESS AND COMPOUNDS FOR SAME

The present invention relates to the treatment of disorders associated with oxidative stress including neuropathic pain and small synthetically derived compounds for treating such disorders.

Method for preparing olefine aldehyde by catalyzing terminal alkyne or terminal conjugated eneyne and diphosphine ligand used in method

The invention discloses a method for preparing olefine aldehyde by catalyzing terminal alkyne or terminal conjugated eneyne and a diphosphine ligand used in the method. According to the invention, indole-substituted phosphoramidite diphosphine ligand which is stable in air and insensitive to light is synthesized by utilizing a continuous one-pot method, and the indole-substituted phosphoramidite diphosphine ligand and a rhodium catalyst are used for jointly catalyzing to successfully achieve a hydroformylation reaction of aromatic terminal alkyne and terminal conjugated eneyne under the condition of synthesis gas for the first time, so that an olefine aldehyde structure compound can be rapidly and massively prepared, and particularly, a polyolefine aldehyde structure compound which is more difficult to synthesize in the prior art can be easily prepared and synthesized, and a novel method is provided for synthesis and modification of drug molecules, intermediates and chemical products.

Substrate-Controlled Chemo-/Enantioselective Synthesis of α-Benzylated Enals and Chiral Cyclopropane-Fused 2-Chromanone Derivatives

Substrate-controlled cascade reactions between α,β-unsaturated aldehydes or their analogues and 2,4-dinitrobenzyl chloride in the presence of a chiral secondary amine as the catalyst and base were developed, to obtain a broad spectrum of α-benzylated enals and enantioenriched cyclopropane-fused chroman-2-one derivatives. The cyclopropane-tethered iminium ion clearly served as a key intermediate in these reactions to trigger stereochemical outcomes, one of which was supported by a control experiment. (Figure presented.).

Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics

Nicotinamide N-methyltransferase (NNMT) methylates nicotinamide (vitamin B3) to generate 1-methylnicotinamide (MNA). NNMT overexpression has been linked to a variety of diseases, most prominently human cancers, indicating its potential as a therapeutic target. The development of small-molecule NNMT inhibitors has gained interest in recent years, with the most potent inhibitors sharing structural features based on elements of the nicotinamide substrate and the S-adenosyl-l-methionine (SAM) cofactor. We here report the development of new bisubstrate inhibitors that include electron-deficient aromatic groups to mimic the nicotinamide moiety. In addition, a trans-alkene linker was found to be optimal for connecting the substrate and cofactor mimics in these inhibitors. The most potent NNMT inhibitor identified exhibits an IC50 value of 3.7 nM, placing it among the most active NNMT inhibitors reported to date. Complementary analytical techniques, modeling studies, and cell-based assays provide insights into the binding mode, affinity, and selectivity of these inhibitors.

Enantioselective Organocatalytic Synthesis of 1,2,3-Trisubstituted Cyclopentanes

An organocatalytic asymmetric domino Michael/α-alkylation reaction between enals and non-stabilized alkyl halides has been developed. Chiral secondary amine catalyzed cyclization reaction of 1-bromo-3-nitropropane with α,β-unsaturated aldehydes provides 1,2,3-trisubstituted cyclopentane carbaldehydes with high diastereo- (dr up to 8 : 1) and enantioselectivities (ee up to 96 %).

Selective Rhodium-Catalyzed Hydroformylation of Terminal Arylalkynes and Conjugated Enynes to (Poly)enals Enabled by a π-Acceptor Biphosphoramidite Ligand

The hydroformylation of terminal arylalkynes and enynes offers a straightforward synthetic route to the valuable (poly)enals. However, the hydroformylation of terminal alkynes has remained a long-standing challenge. Herein, an efficient and selective Rh-catalyzed hydroformylation of terminal arylalkynes and conjugated enynes has been achieved by using a new stable biphosphoramidite ligand with strong π-acceptor capacity, which affords various important E-(poly)enals in good yields with excellent chemo- and regioselectivity at low temperatures and low syngas pressures.

One-Pot Preparation of (E)-α,β-Unsaturated Aldehydes by a Julia-Kocienski Reaction of 2,2-Dimethoxyethyl PT Sulfone Followed by Acid Hydrolysis

(E)-α,β-Unsaturated aldehydes were synthesized by the Julia-Kocienski reaction of 2,2-dimethoxyethyl 1-phenyl-1H-tetrazol-5-yl (PT) sulfone 3 with various aldehydes, followed by acid hydrolysis. The reaction could be carried out in one pot, and various (E)-α,β-unsaturated aldehydes were obtained in a short time and with high yields.

Iron-Catalyzed ?±,?-Dehydrogenation of Carbonyl Compounds

An iron-catalyzed α,β-dehydrogenation of carbonyl compounds was developed. A broad spectrum of carbonyls or analogues, such as aldehyde, ketone, lactone, lactam, amine, and alcohol, could be converted to their α,β-unsaturated counterparts in a simple one-step reaction with high yields.

Amino acid derivative, feed composition and application thereof

The invention provides an amino acid derivative, a feed composition and application thereof, and belongs to the technical field of animal feed additives. The amino acid derivative is a compound with astructure shown as a formula (I), and a stereoisomer, a tautomer, a solvate, a metabolite, a feed acceptable salt or a prodrug thereof. In formula (I) shown in the specification, Z is a C1-C3 alkylene group. X is an indole ring group with a structure shown as a formula (II). The formula (II) is shown in the specification, wherein Y is phenyl with the structure shown in the formula (III) shown inthe specification. The amino acid derivative is used as an animal feed additive, and can promote the growth of animals and improve the feed conversion.